Alnylam Pharmaceuticals, Inc.

China Universal Asset Management Co., Ltd. ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

25,267

Value ($000)

10,047

Weight

0.8%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	10,047	0.8%	25,267	12/31/2025
2025 Q3	11/10/2025	10,391	0.9%	22,787	9/30/2025
2025 Q2	8/28/2025	9,071	0.9%	27,817	6/30/2025